Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide

in: OncoImmunology | 2018

von Serena Pellegatta | Marica Eoli | Valeria Cuccarini | +17